XRCC6 and chronic leukemia: SIRT1 inhibition reduced NHEJ repair efficiency in the K562 chronic leukemia cell line probably via Ku70 inactivation, which is a key component in the NHEJ pathway, indicating an important role for SIRT1 in the DNA damage response of myeloid leukemia.